1. Home
  2. LB vs INVA Comparison

LB vs INVA Comparison

Compare LB & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LB
  • INVA
  • Stock Information
  • Founded
  • LB 1992
  • INVA 1996
  • Country
  • LB United States
  • INVA United States
  • Employees
  • LB N/A
  • INVA N/A
  • Industry
  • LB
  • INVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • LB
  • INVA Health Care
  • Exchange
  • LB NYSE
  • INVA Nasdaq
  • Market Cap
  • LB 1.1B
  • INVA 1.2B
  • IPO Year
  • LB 2024
  • INVA 2004
  • Fundamental
  • Price
  • LB $57.02
  • INVA $17.90
  • Analyst Decision
  • LB Buy
  • INVA Buy
  • Analyst Count
  • LB 8
  • INVA 1
  • Target Price
  • LB $40.63
  • INVA N/A
  • AVG Volume (30 Days)
  • LB 603.7K
  • INVA 684.8K
  • Earning Date
  • LB 11-06-2024
  • INVA 11-06-2024
  • Dividend Yield
  • LB 0.17%
  • INVA N/A
  • EPS Growth
  • LB N/A
  • INVA 46.55
  • EPS
  • LB 0.30
  • INVA 0.99
  • Revenue
  • LB $90,912,000.00
  • INVA $352,745,000.00
  • Revenue This Year
  • LB $57.77
  • INVA $16.20
  • Revenue Next Year
  • LB $44.23
  • INVA N/A
  • P/E Ratio
  • LB $193.83
  • INVA $18.62
  • Revenue Growth
  • LB 26.93
  • INVA 21.46
  • 52 Week Low
  • LB $18.75
  • INVA $14.33
  • 52 Week High
  • LB $80.82
  • INVA $21.28
  • Technical
  • Relative Strength Index (RSI)
  • LB N/A
  • INVA 34.59
  • Support Level
  • LB N/A
  • INVA $18.33
  • Resistance Level
  • LB N/A
  • INVA $18.69
  • Average True Range (ATR)
  • LB 0.00
  • INVA 0.33
  • MACD
  • LB 0.00
  • INVA -0.05
  • Stochastic Oscillator
  • LB 0.00
  • INVA 13.61

About LB LANDBRIDGE COMPANY LLC

LandBridge Co LLC is engaged in managing land and resources to support and promote oil and natural gas development. It generate revenue streams from the use of its surface acreage, the sale of resources from land and oil and gas royalties.

About INVA Innoviva Inc.

Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Share on Social Networks: